Form D · Biotechnology
Ideaya Biosciences, Inc.
South San Francisco, CA · CIK 0001676725
Offering snapshot reported May 11, 2018 · SEC filing
- Reported sold
- $94M Offering amount: $94M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2018 | Initial | $94,019,988 | No comparison | 23 | SEC filing |
| Aug 26, 2016 | Initial | $17,360,532 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-312153
Source: Form D, filed May 11, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Daniels | Director |
| John D. Diekman | Director |
| Michael P. Dillon | Executive |
| Jeffrey Hager | Executive |
| Yujiro S. Hata | Director, Executive |
| Edward Hu | Director |
| Terry Rosen | Director |
| Thilo Schroeder | Director |
| Timothy Shannon | Director |
| Tim Smith | Executive |
| Jeffrey Stein | Director |
| Paul A. Stone | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7000 Shoreline Court Suite 350
South San Francisco, CA, 94080
South San Francisco, CA, 94080